Technology

An AI revolution in drugmaking is under way

January 6, 2026

An AI revolution in drugmaking is under way The Economist Published on: Jan 06, 2026 10:43 am IST Read this news in brief form Share Via Copy Link Insilico now has a pipeline of more than 40 AI-developed drugs it is developing for conditions such as cancer, bowel and kidney disease. PATRICK SCHWAB is not your normal pharmaceutical researcher and his workplace is not your normal pharmaceutical laboratory. It has neither benches nor bubbling liquids.

Representative image

Credit: Hindustantimes

Key Highlights

White lab coats are absent, too.
Instead, Dr Schwab is dressed entirely in black.
But that is fitting attire for one whose workplace is in King’s Cross, an area that was once railway yards and industrial buildings but is now, after a makeover, one of London’s most achingly trendy districts.
PREMIUM Representative image.
Dr Schwab works for GSK, a drug company.

technology

Sources

An AI revolution in drugmaking is under way

This quick summary is automatically generated using AI based on reports from multiple news sources. The content has not been reviewed or verified by humans. For complete details, accuracy, and context, please refer to the original published articles.

An AI revolution in drugmaking is under way

Key Highlights

Sources

Related Stories

These high capacity geysers are ideal for dropping temperature in North India

Amazon Republic Day Sale starts on Jan 16; Here are expected deals on soundbars from top brands

Tech companies must address impact on natural resources, failure threatens firms long term resilience: WEF